Work

S6141 Vedolizumab for Severe Refractory Acute Cellular Rejection After Intestinal Transplantation

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001153024.89730.e5

Authors: Michael Gianarakis, Robert E. Carroll

Language: English

Topic: Transplantation: Methods and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7114790412

Cites:

Cited by:

Related to: